参考文献/References:
[1] Badji A,Youwakim J,Cooper A,et al.Vascular cognitive impairment-past, present, and future challenges[J].Ageing Res Rev,2023,90:102042.
[2] Yang T,Sun Y,Lu ZY,et al.The impact of cerebrovascular aging on vascular cognitive impairment and dementia[J].Ageing Res Rev,2017,34:15-29.
[3] Jellinger KA.Pathology and pathogenesis of vascular cognitive impairment-a critical update[J].Front Aging Neurosci,2013,5:17.
[4] Gorelick PB,Scuteri A,Black SE,et al.Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association[J].Stroke,2011,42(9):2672-2713.
[5] Dixon SJ,Lemberg KM,Lamprecht MR,et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.
[6] Zhou YY,Lin W,Rao T,et al.Ferroptosis and its potential role in the nervous system diseases[J].J Inflamm Res,2022,15:1555-1574.
[7] Belaidi AA,Bush AI.Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics[J].J Neurochem,2016,139 Suppl 1:179-197.
[8] Eid R,Arab NTT,Greenwood MT.Iron mediated toxicity and programmed cell death: a review and a re-examination of existing paradigms[J].Biochim Biophys Acta Mol Cell Res,2017,1864(2):399-430.
[9] Burdo JR,Menzies SL,Simpson IA,et al.Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat[J].J Neurosci Res,2001,66(6):1198-1207.
[10] Fang XX,Cai ZX,Wang H,et al.Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis[J].Circ Res,2020,127(4):486-501.
[11] Raha AA,Biswas A,Henderson J,et al.Interplay of ferritin accumulation and ferroportin loss in ageing brain: implication for protein aggregation in down syndrome dementia, alzheimer's, and Parkinson's diseases[J].Int J Mol Sci,2022,23(3):1060.
[12] Bai YS,Meng LJ,Han L,et al.Lipid storage and lipophagy regulates ferroptosis[J].Biochem Biophys Res Commun,2019,508(4):997-1003.
[13] Ji YY,Zheng K,Li SM,et al.Insight into the potential role of ferroptosis in neurodegenerative diseases[J].Front Cell Neurosci,2022,16:1005182.
[14] Doll S,Proneth B,Tyurina YY,et al.ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J].Nat Chem Biol,2017,13(1):91-98.
[15] Cao JY,Dixon SJ.Mechanisms of ferroptosis[J].Cell Mol Life Sci,2016,73(11/12):2195-2209.
[16] Hider RC,Kong XL.Glutathione: a key component of the cytoplasmic labile iron pool[J].Biometals,2011,24(6):1179-1187.
[17] Friedmann Angeli JP,Schneider M,Proneth B,et al.Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J].Nat Cell Biol,2014,16(12):1180-1191.
[18] Sun Y,Zheng YF,Wang CX,et al.Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells[J].Cell Death Dis,2018,9(7):753.
[19] Calabrese V,Giordano J,Signorile A,et al.Major pathogenic mechanisms in vascular dementia: roles of cellular stress response and hormesis in neuroprotection[J].J Neurosci Res,2016,94(12):1588-1603.
[20] De Silva TM,Faraci FM.Microvascular dysfunction and cognitive impairment[J].Cell Mol Neurobiol,2016,36(2):241-258.
[21] Yu WW,Li Y,Hu J,et al.A study on the pathogenesis of vascular cognitive impairment and dementia: the chronic cerebral hypoperfusion hypothesis[J].J Clin Med,2022,11(16):4742.
[22] Abbott NJ.Rönnbäck L,Hansson E.Astrocyte-endothelial interactions at the blood-brain barrier[J].Nat Rev Neurosci,2006,7(1):41-53.
[23] Rajeev V,Fann DY,Dinh QN,et al.Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment[J].Theranostics,2022,12(4):1639-1658.
[24] Kara B,Gordon MN,Gifani M,et al.Vascular and nonvascular mechanisms of cognitive impairment and dementia[J].Clin Geriatr Med,2023,39(1):109-122.
[25] Brown R,Benveniste H,Black SE,et al.Understanding the role of the perivascular space in cerebral small vessel disease[J].Cardiovasc Res,2018,114(11):1462-1473.
[26] Carson MJ,Doose JM,Melchior B,et al.CNS immune privilege: hiding in plain sight[J].Immunol Rev,2006,213(1):48-65.
[27] Yilmaz G,Granger DN.Leukocyte recruitment and ischemic brain injury[J].Neuromolecular Med,2010,12(2):193-204.
[28] Guo SZ,Kim WJ,Lok J,et al.Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons[J].Proc Natl Acad Sci U S A,2008,105(21):7582-7587.
[29] SHI X,OHTA Y,SHANG J,et al.Neuroprotective effects of SMTP-44D in mice stroke model in relation to neurovascular unit and trophic coupling[J].Journal of Cerebral Blood Flow and Metabolism,2019:39.
[30] Saggu R,Schumacher T,Gerich F,et al.Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia[J].Acta Neuropathol Commun,2016,4(1):76.
[31] Arai K,Lo EH.An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells[J].J Neurosci,2009,29(14):4351-4355.
[32] Wolburg H,Noell S,Fallier-Becker P,et al.The disturbed blood-brain barrier in human glioblastoma[J].Mol Aspects Med,2012,33(5/6):579-589.
[33] Thomas GEC,Leyland LA,Schrag AE,et al.Brain iron deposition is linked with cognitive severity in Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2020,91(4):418-425.
[34] Sun CY,Wu Y,Ling C,et al.Deep gray matter iron deposition and its relationship to clinical features in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy patients: a 7.0-T magnetic resonance imaging study[J].Stroke,2020,51(6):1750-1757.
[35] Yan N,Zhang JJ.The emerging roles of ferroptosis in vascular cognitive impairment[J].Front Neurosci,2019,13:811.
[36] Urrutia P,Aguirre P,Esparza A,et al.Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes Iron accumulation in central nervous system cells[J].J Neurochem,2013,126(4):541-549.
[37] Tuo QZ,Lei P,Jackman KA,et al.Tau-mediated iron export prevents ferroptotic damage after ischemic stroke[J].Mol Psychiatry,2017,22(11):1520-1530.
[38] Krzy(·overz)anowska W,Pomierny B,Filip M,et al.Glutamate transporters in brain ischemia: to modulate or not?[J].Acta Pharmacol Sin,2014,35(4):444-462.
[39] Frank C,Hoffmann T,Zelder O,et al.Enhanced glutamate synthesis and export by the thermotolerant emerging industrial workhorse bacillus methanolicus in response to high osmolarity[J].Front Microbiol,2021,12:640980.
[40] Sarutipaiboon I,Settasatian N,Komanasin N,et al.Association of genetic variations in NRF2, NQO1, HMOX1, and MT with severity of coronary artery disease and related risk factors[J].Cardiovasc Toxicol,2020,20(2):176-189.
[41] Nishizawa H,Yamanaka M,Igarashi K.Ferroptosis:regulation by competition between NRF2 and BACH1 and propagation of the death signal[J].FEBS J,2023,290(7):1688-1704.
[42] Li Y,Zhang ED,Yang H,et al.Gastrodin ameliorates cognitive dysfunction in vascular dementia rats by suppressing ferroptosis via the regulation of the Nrf2/Keap1-GPx4 signaling pathway[J].Molecules,2022,27(19):6311.
[43] Yan N,Xu ZP,Qu CH,et al.Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-κB signal pathway[J].Int Immunopharmacol,2021,98:107844.
[44] Lee JM,Lee JH,Song MK,et al.NXP031 improves cognitive impairment in a chronic cerebral hypoperfusion-induced vascular dementia rat model through Nrf2 signaling[J].Int J Mol Sci,2021,22(12):6285.
[45] Doll S,Freitas FP,Shah R,et al.FSP1 is a glutathione-independent ferroptosis suppressor[J].Nature,2019,575(7784):693-698.
[46] Peng CL,Jiang N,Zhao JF,et al.Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury[J].Toxicol Appl Pharmacol,2021,414:115408.
[47] Yigitkanli K,Zheng Y,Pekcec A,et al.Increased 12/15-lipoxygenase leads to widespread brain injury following global cerebral ischemia[J].Transl Stroke Res,2017,8(2):194-202.